Encapson obtains B-Series follow-on funding from existing investors
- Encapson’s existing VC’s, Twente Technology Fund, OOST NL and NextGen Ventures invested an undisclosed amount to enable Encapson completing the final development phase of the Sono-Coat™ (M)etal and (P)olymer coating platforms. The first Sono-Coat™ product is targeted for CE and FDA regulatory approval mid-2020 and reach the market in Q4 2020
- The proceeds will also be used to start development of Sono-Sheath™, Encapson’s first own product for use in the Biopsy and Vascular Access field
Note for the Press
Encapson has developed Sono-Coat™; an innovative echogenic coating system to improve the ultrasound visibility of medical devices in the body. The Sono-Coat™ technology is based on a coating matrix containing acoustically reflective microspheres. The microspheres scatter the ultrasound waves in all directions. The enhanced reflection leads to crystal clear and sharp images on the ultrasound screen. The Sono-Coat™ technology platform consists of two coating systems: the M-series for needles and the P-Series for catheters.
Sono-Coat™ enables precise targeting of objects in deeper tissue structures such as liver and kidney biopsies, facilitates vascular access, setting peripheral nerve block and tip confirmation of CVC, PICC, Drainage and Regional Anaesthesia catheters. The unmatched ultrasound visibility of Sono-Coat™ supports the physician in performing accurate, safe and error-free ultrasound-guided procedures.
Encapson provides coating services to the medtech industry. We develop advanced visibility solutions for a large variety of products creating unique value for your portfolio. Our company is ISO-13485:2016 certified and delivers high-quality products that meet stringent regulatory and end-user requirements.
For more information please contact us